Safety and tolerance of dose-dense Epirubicin and Cyclophosphamide (EC) with Pegfilgrastim for Japanese patients with early breast cancer

被引：0
|
作者：
Watanabe, K. [1 ]
Yamamoto, M. [1 ]
Sato, M. [1 ]
Tomioka, N. [1 ]
Takahashi, M. [1 ]
机构：
[1] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
来源：
BREAST | 2017年 / 32卷
关键词：
D O I：
10.1016/S0960-9776(17)30118-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P017
引用
收藏
页码：S27 / S28
页数：2
相关论文
共 50 条
  • [1] Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer
    Wang, Xinguang
    He, Yingjian
    Wang, Tianfeng
    Xie, Yuntao
    Li, Jinfeng
    Ouyang, Tao
    Fan, Zhaoqing
    SUPPORTIVE CARE IN CANCER, 2019, 27 (08) : 3019 - 3025
  • [2] Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer
    Xinguang Wang
    Yingjian He
    Tianfeng Wang
    Yuntao Xie
    Jinfeng Li
    Tao Ouyang
    Zhaoqing Fan
    Supportive Care in Cancer, 2019, 27 : 3019 - 3025
  • [3] Efficacy of a half-dose pegfilgrastim for dose-dense doxorubicin and cyclophosphamide in Japanese breast cancer patients
    Mizuno, Y.
    Fuchikami, H.
    Takeda, N.
    Inoue, Y.
    Seto, H.
    Sato, K.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S97 - S98
  • [4] Efficacy of reduced dose of pegfilgrastim in Japanese breast cancer patients receiving dose-dense doxorubicin and cyclophosphamide therapy
    Mizuno, Yoshio
    Fuchikami, Hiromi
    Takeda, Naoko
    Iwai, Masaru
    Sato, Kazuhiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (01) : 12 - 17
  • [5] Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients
    Sanna, G.
    Pestrin, M.
    Zafarana, E.
    Biagioni, C.
    Cavaciocchi, D.
    Turner, N.
    Di Leo, A.
    Biganzoli, L.
    BREAST, 2013, 22 (05): : 926 - 932
  • [6] Primary dose-dense epirubicin/cyclophosphamide→docetaxel in breast cancer: preliminary results
    Cocciolone, V.
    Cannita, K.
    Bruera, G.
    Bafile, A.
    Coletti, G.
    Resta, V.
    Ciccozzi, A.
    Dalmas, A.
    Ficorella, C.
    Ricevuto, E.
    BREAST, 2015, 24 : S100 - S101
  • [7] Prolonged Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel in Breast Cancer Is Feasible
    Dang, Chau
    D'Andrea, Gabriella
    Lake, Diana
    Sugarman, Steve
    Fornier, Monica
    Moynahan, Mary Ellen
    Gilewski, Theresa
    Hurria, Arti
    Mills, Nancy
    Troso-Sandoval, Tiffany
    George, Roshini
    Robson, Mark
    Dickler, Maura
    Smith, Karen
    Panageas, Katherine S.
    Norton, Larry
    Hudis, Clifford A.
    CLINICAL BREAST CANCER, 2008, 8 (05) : 418 - 424
  • [8] Preoperative dose-dense sequential chemotherapy of epirubicin/ cyclophosphamide followed by docetaxellcapecitabine in patients with early breast cancer: preliminary results
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 158 - 158
  • [9] Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible.
    Dang, C
    Smith, K
    Lake, D
    Fornier, M
    D'Andrea, G
    Seidman, A
    Sklarin, N
    Troso-Sandoval, T
    Sugarman, S
    Gilewski, T
    Robson, M
    Drullinsky, P
    Moynahan, M
    Van Poznak, GR
    Panageas, K
    Smith, M
    Norton, L
    Hudis, C
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S108 - S108
  • [10] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer
    Grassadonia, Antonino
    Cianchetti, Ettore
    Ficorella, Corrado
    Angelucci, Domenico
    Grossi, Simona
    Ricevuto, Enrico
    Zilli, Marinella
    Tinari, Nicola
    Natoli, Clara
    Iacobelli, Stefano
    ANNALS OF ONCOLOGY, 2006, 17 : 97 - 97
12345